![Bill Slattery](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bill Slattery
Investor Relations Kontakt bei
OCULAR THERAPEUTIX, INC.
Profil
Bill Slattery is Vice President-Investor Relations at Ocular Therapeutix, Inc. since 2024.
Mr. Slattery is an Account Manager at Burns McClellan, Inc. Mr. Slattery was VP-Investor Relations & Corporate Communications at ChemoCentryx, Inc.
Aktive Positionen von Bill Slattery
| Unternehmen | Position | Beginn |
|---|---|---|
| OCULAR THERAPEUTIX, INC. | Investor Relations Kontakt | 01.04.2024 |
Burns McClellan, Inc.
 Burns McClellan, Inc. Miscellaneous Commercial ServicesCommercial Services Provides public and investor relations services | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Bill Slattery
| Unternehmen | Position | Ende |
|---|---|---|
| CHEMOCENTRYX, INC. | Investor Relations Kontakt | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
33
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Ocular Therapeutix, Inc.
 Ocular Therapeutix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for retinal diseases & conditions of the eye | Health Technology |
Burns McClellan, Inc.
Burns McClellan, Inc. Miscellaneous Commercial ServicesCommercial Services Provides public and investor relations services | Commercial Services |
